APA (7th ed.) Citation

P, K., M, E., FC, G., U, A., JA, L., G, K., . . . M, R. (2026). Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(1), 60. https://doi.org/10.2967/jnumed.125.271344

Chicago Style (17th ed.) Citation

P, Krausewitz, et al. "Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 1 (2026): 60. https://doi.org/10.2967/jnumed.125.271344.

MLA (9th ed.) Citation

P, Krausewitz, et al. "Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 1, 2026, p. 60, https://doi.org/10.2967/jnumed.125.271344.